Continental Advisors’s Zimmer Biomet ZBH Stock Holding History

Continental Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,150	Closed	-$650K	–	160
2016 Q3	$650K	Buy	5,150 +2,575	+100%	+$318K	0.18%	112
2016 Q2	$301K	Sell	2,575 -7,725	-75%	-$874K	0.09%	114
2016 Q1	$1.07M	Buy	+10,300	New	+$996K	0.3%	87

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Continental Advisors's ZBH Position: Q2 2026 in Review

Continental Advisors opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 17,500 shares worth $1.51M. The stake represents 0.64% of the portfolio and ranks #38 among its holdings.

909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Continental Advisors held 17,500 shares of Zimmer Biomet worth $1.51M as of Q2 2026.
Zimmer Biomet was a new Continental Advisors position in Q2 2026.
Zimmer Biomet made up 0.64% of Continental Advisors's portfolio in Q2 2026, its #38 holding.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Continental Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.